Last update 21 Nov 2024

MNC-168

Overview

Basic Info

Drug Type
Live biotherapeutic products
Synonyms
Target-
Mechanism
Bacteria replacements, Microbiome modulators
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Guangzhou Colony Biotechnology Co., Ltd.Guangzhou Colony Biotechnology Co., Ltd.
Active Organization
Guangzhou Colony Biotechnology Co., Ltd.Guangzhou Colony Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with MNC-168
CTR20233170 / RecruitingPhase 1
活菌MNC-168肠溶胶囊分别联用帕博利珠单抗、舒格利单抗在晚期恶性实体瘤受试者中的安全性、耐受性、药代动力学特征及初步有效性的I期临床研究
[Translation] Phase I clinical study on the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of live bacteria MNC-168 enteric-coated capsules combined with pembrolizumab and sugemalimab in subjects with advanced malignant solid tumors
CTR20222230 / RecruitingPhase 1
活菌MNC-168肠溶胶囊单药口服在晚期恶性实体瘤受试者中的安全性、耐受性、药代动力学特征及初步有效性的I期临床研究
[Translation] A phase I clinical study on the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of oral administration of live bacteria MNC-168 enteric-coated capsules in subjects with advanced malignant solid tumors
NCT05383703 / Unknown statusPhase 1
A Phase I Clinical Study on Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of MNC-168 Enteric-coated Capsules in Patients With Advanced Malignant Solid Tumors
100 Clinical Results associated with MNC-168
Login to view more data
100 Translational Medicine associated with MNC-168
Login to view more data
100 Patents (Medical) associated with MNC-168
Login to view more data
100 Deals associated with MNC-168
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmDiscovery-
Guangzhou Colony Biotechnology Co., Ltd.Guangzhou Colony Biotechnology Co., Ltd.
30 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free